Skip to main content
. 2013 Jan 20;16(1):20–24. [Article in Chinese] doi: 10.3779/j.issn.1009-3419.2013.01.04

2.

足叶乙甙联合奥沙利铂和足叶乙甙联合顺铂的疗效评价(n=69)

Efficacy evaluation of etoposide plus oxaliplatin (EO) and etoposide plus cisplatin (EP) (n=69)

Efficacy EO group (n=34) EP group (n=35) P
CR: completely response; PR: partial response; SD: stable disease; PD: progressive disease; RR: response rate; DCR: disease control rate; PFS:progression free survival; OS: overall survival.
CR 3 2 -
PR 16 17 -
SD 9 8 -
PD 6 8 -
RR 55.9% 54.3% 0.894
DCR 82.4% 77.1% 0.591
PFS (month) 5.5 4.7 0.638
OS (month) 10.5 9.1 0.862